相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Efficacy and safety of duloxetine for treatment of fibromyalgia in patients with or without major depressive disorder: Results from a 6-month, randomized, double-blind, placebo-controlled, fixed-dose trial
I. Jon Russell et al.
PAIN (2008)
Duloxetine does not relieve painful physical symptoms in depression: A meta-analysis
Glen I. Spielmans
PSYCHOTHERAPY AND PSYCHOSOMATICS (2008)
Pharmacologic management of neuropathic pain: Evidence-based recommendations
Robert H. Dworkin et al.
PAIN (2007)
An open-label 52-week clinical extension comparing duloxetine with routine care in patients with diabetic peripheral neuropathic pain
Joachim F. Wernicke et al.
PAIN MEDICINE (2007)
The safety and tolerability of duloxetine in depressed elderly patients with and without medical comorbidity
T. N. Wise et al.
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (2007)
The impact of neuropathic pain on health-related quality of life - Review and implications
Mark P. Jensen et al.
NEUROLOGY (2007)
An evaluation of the cardiovascular safety profile of duloxetine - Findings from 42 placebo-controlled studies
Joachim Wernicke et al.
DRUG SAFETY (2007)
Duloxetine for the management of diabetic peripheral neuropathic pain: Evidence-based findings from post hoc analysis of three multicenter, randomized, double-blind, placebo-controlled, parallel-group studies
Daniel K. Kajdasz et al.
CLINICAL THERAPEUTICS (2007)
EFNS guidelines on pharmacological treatment of neuropathic pain
N. Attal et al.
EUROPEAN JOURNAL OF NEUROLOGY (2006)
A randomized controlled trial of duloxetine in diabetic peripheral neuropathic pain
J. F. Wernicke et al.
NEUROLOGY (2006)
Dose-response relationship of duloxetine in placebo-controlled clinical trials in patients with major depressive disorder
Per Bech et al.
PSYCHOPHARMACOLOGY (2006)
Duloxetine for patients with diabetic peripheral neuropathic pain: A 6-month open-label safety study
Joel Raskin et al.
PAIN MEDICINE (2006)
Duloxetine 60 mg once daily in the treatment of milder major depressive disorder
DGS Perahia et al.
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (2006)
Epidemiology and treatment of neuropathic pain: The UK primary care perspective
Gillian C. Hall et al.
PAIN (2006)
A randomized, double-blind, placebo-controlled trial of duloxetine in the treatment of women with fibromyalgia with or without major depressive disorder
LM Arnold et al.
PAIN (2005)
Algorithm for neuropathic pain treatment: An evidence based proposal
NB Finnerup et al.
PAIN (2005)
A double-blind, randomized multicenter trial comparing duloxetine with placebo in the management of diabetic peripheral neuropathic pain
J Raskin et al.
PAIN MEDICINE (2005)
Analgesic therapy in postherpetic neuralgia: A quantitative systematic review
K Hempenstall et al.
PLOS MEDICINE (2005)
Duloxetine vs. placebo in patients with painful diabetic neuropathy
DJ Goldstein et al.
PAIN (2005)
Efficacy and safety of opioid agonists in the treatment of neuropathic pain of nonmalignant origin - Systematic review and meta-analysis of randomized controlled trials
E Eisenberg et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2005)
Duloxetine 60 mg once-daily in the treatment of painful physical symptoms in patients with major depressive disorder
SK Brannan et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2005)
Systematic review of topical capsaicin for the treatment of chronic pain
L Mason et al.
BMJ-BRITISH MEDICAL JOURNAL (2004)
A double-blind, multicenter trial comparing duloxetine with placebo in the treatment of fibromyalgia patients with or without major depressive disorder
LM Arnold et al.
ARTHRITIS AND RHEUMATISM (2004)
Effects of duloxetine on painful physical symptoms associated with depression
DJ Goldstein et al.
PSYCHOSOMATICS (2004)
Teasing apart quality and validity in systematic reviews: an example from acupuncture trials in chronic neck and back pain
LA Smith et al.
PAIN (2000)
An evaluation of homogeneity tests in meta-analyses in pain using simulations of individual patient data
DJ Gavaghan et al.
PAIN (2000)
分享论文
